Icon

TRIZIVIR (nda021205)- (EQ 300MG BASE;150MG;300MG)

ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE VIIV HLTHCARE
EQ 300MG BASE;150MG;300MG
Yes No
2018-Nov-14 Expired
None None
None No
TRIZIVIR, a combination of abacavir, lamivudine, and zidovudine, each nucleoside analogue HIV-1 reverse transcriptase inhibitors, is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection.
1 1 1
Total Other Developers 1
Drugs with Suitability No
EQ 300MG BASE;150MG;300MG ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 1
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** *** ***** ******* *********** ****-*, **** **. *-* *** *-*-*, ******* ******** **** ***** **, ****. ****, ******* ****, ****. ****, *********, ****** ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.